{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T18:20:36Z","timestamp":1794594036048,"version":"4.9.1"},"reference-count":100,"publisher":"American Association for Cancer Research (AACR)","issue":"3","funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["1X01HD100702-01"],"award-info":[{"award-number":["1X01HD100702-01"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA197695"],"award-info":[{"award-number":["R35CA197695"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA021765"],"award-info":[{"award-number":["P30CA021765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Relapsed and refractory T-lineage acute lymphoblastic leukemia (T-ALL) has a poor prognosis, emphasizing the need to identify high-risk patients. T-ALL classification has relied on immunophenotype, including identification of early T-cell precursor ALL, but few genetic alterations reproducibly predict outcome in T-ALL independently of measurable residual disease. Here, the biologic and genetic basis of T-ALL is reviewed, with an emphasis on large-scale genomic analyses that have shed light on the spectrum of genetic subtypes, their drivers, mechanisms of oncogene activation, and developmental stage. We describe how genomics-based approaches can improve T-ALL classification and risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Whole-genome and whole-transcriptome sequencing enable biologically and clinically meaningful T-ALL subtype classification with greater precision than immunophenotype-based approaches. The genomic landscape of T-ALL is heavily influenced by noncoding alterations, posing a challenge for clinical applications, as their detection often requires whole-genome sequencing. Studies have identified genomic subtypes and genetic alterations that improve the accuracy of patient outcome prediction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-25-0206","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:22:09Z","timestamp":1775744529000},"page":"353-368","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genomic Insights into the Biology of T-lineage Acute Lymphoblastic Leukemia"],"prefix":"10.1158","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6128-9985","authenticated-orcid":false,"given":"Petri","family":"Po\u0308lo\u0308nen","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Department of Pathology, , Memphis, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7373-8987","authenticated-orcid":false,"given":"David T.","family":"Teachey","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania."},{"id":[{"id":"https:\/\/ror.org\/01z7r7q48","id-type":"ROR","asserted-by":"publisher"}],"name":"The Children\u2019s Hospital of Philadelphia 3 Division of Oncology, , Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-1850","authenticated-orcid":false,"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 1 Department of Pathology, , Memphis, Tennessee."},{"id":[{"id":"https:\/\/ror.org\/02r3e0967","id-type":"ROR","asserted-by":"publisher"}],"name":"St. Jude Children\u2019s Research Hospital 4 Center of Excellence for Leukemia Studies, , Memphis, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2026111109162702000_bib1","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"key":"2026111109162702000_bib2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","article-title":"T-cell acute lymphoblastic leukemia","volume":"2016","author":"Raetz","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2026111109162702000_bib3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"2026111109162702000_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2017-04-778829","article-title":"Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia","volume":"131","author":"Petit","year":"2018","journal-title":"Blood"},{"key":"2026111109162702000_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/leu.2015.206","article-title":"Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial","volume":"30","author":"Jenkinson","year":"2016","journal-title":"Leukemia"},{"key":"2026111109162702000_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41375-021-01334-x","article-title":"Prognostic value of oncogenetic mutations in pediatric T acute lymphoblastic leukemia: a comparison of UKALL2003 and FRALLE2000T protocols","volume":"36","author":"Taj","year":"2022","journal-title":"Leukemia"},{"key":"2026111109162702000_bib7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"2026111109162702000_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"2026111109162702000_bib9","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.2023020678","article-title":"Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children\u2019s Oncology Group study","volume":"142","author":"Wood","year":"2023","journal-title":"Blood"},{"key":"2026111109162702000_bib10","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.2023022920","article-title":"Classification and risk stratification in T-lineage acute lymphoblastic leukemia","volume":"145","author":"P\u00f6l\u00f6nen","year":"2025","journal-title":"Blood"},{"key":"2026111109162702000_bib11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3324\/haematol.2024.285643","article-title":"Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma","volume":"110","author":"Hughes","year":"2025","journal-title":"Haematologica"},{"key":"2026111109162702000_bib12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukaemia","volume":"632","author":"P\u00f6l\u00f6nen","year":"2024","journal-title":"Nature"},{"key":"2026111109162702000_bib13","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood.2023023754","article-title":"NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients","volume":"144","author":"Simonin","year":"2024","journal-title":"Blood"},{"key":"2026111109162702000_bib14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(25)00864-5","article-title":"Acute lymphocytic leukaemia","volume":"406","author":"Kantarjian","year":"2025","journal-title":"Lancet"},{"key":"2026111109162702000_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.2023023155","article-title":"How I treat ETP-ALL in children","volume":"145","author":"Summers","year":"2025","journal-title":"Blood"},{"key":"2026111109162702000_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.6004\/jnccn.2025.0006","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2025, NCCN clinical practice guidelines in Oncology","volume":"23","author":"Inaba","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"2026111109162702000_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MOP.0000000000000171","article-title":"Update on biology and treatment of T-cell acute lymphoblastic leukaemia","volume":"27","author":"Patrick","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"2026111109162702000_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/bloodadvances.2023010303","article-title":"Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia","volume":"8","author":"Shimony","year":"2024","journal-title":"Blood Adv"},{"key":"2026111109162702000_bib19","doi-asserted-by":"crossref","first-page":"750789","DOI":"10.3389\/fonc.2021.750789","article-title":"Early T-cell precursor acute lymphoblastic leukemia: diagnosis, updates in molecular pathogenesis, management, and novel therapies","volume":"11","author":"Sin","year":"2021","journal-title":"Front Oncol"},{"key":"2026111109162702000_bib20","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"2026111109162702000_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri2232","article-title":"Launching the T-cell-lineage developmental programme","volume":"8","author":"Rothenberg","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2026111109162702000_bib22","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"2026111109162702000_bib23","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"2026111109162702000_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"2026111109162702000_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International Consensus Classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"key":"2026111109162702000_bib26","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","article-title":"Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study","volume":"118","author":"Schrappe","year":"2011","journal-title":"Blood"},{"key":"2026111109162702000_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","article-title":"Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy","volume":"2","author":"Jeha","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"2026111109162702000_bib28","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","article-title":"Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell leukemia","volume":"11","author":"Montefiori","year":"2021","journal-title":"Cancer Discov"},{"key":"2026111109162702000_bib29","first-page":"773","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood"},{"key":"2026111109162702000_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2017.09.001","article-title":"Non-coding transcription instructs chromatin folding and compartmentalization to dictate enhancer-promoter communication and T cell fate","volume":"171","author":"Isoda","year":"2017","journal-title":"Cell"},{"key":"2026111109162702000_bib31","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.1259037","article-title":"Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element","volume":"346","author":"Mansour","year":"2014","journal-title":"Science"},{"key":"2026111109162702000_bib32","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood-2017-03-771162","article-title":"Whole-genome noncoding sequence analysis in T-cell acute lymphoblastic leukemia identifies oncogene enhancer mutations","volume":"129","author":"Hu","year":"2017","journal-title":"Blood"},{"key":"2026111109162702000_bib33","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood-2016-09-742148","article-title":"Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia","volume":"129","author":"Rahman","year":"2017","journal-title":"Blood"},{"key":"2026111109162702000_bib34","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nm.3665","article-title":"A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia","volume":"20","author":"Herranz","year":"2014","journal-title":"Nat Med"},{"key":"2026111109162702000_bib35","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood.2024024300","article-title":"Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia","volume":"144","author":"Rahman","year":"2024","journal-title":"Blood"},{"key":"2026111109162702000_bib36","doi-asserted-by":"crossref","first-page":"e20231349","DOI":"10.1084\/jem.20231349","article-title":"Native stem cell transcriptional circuits define cardinal features of high-risk leukemia","volume":"222","author":"Wang","year":"2025","journal-title":"J Exp Med"},{"key":"2026111109162702000_bib37","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1126\/science.aad9024","article-title":"Activation of proto-oncogenes by disruption of chromosome neighborhoods","volume":"351","author":"Hnisz","year":"2016","journal-title":"Science"},{"key":"2026111109162702000_bib38","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41588-020-0602-9","article-title":"Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia","volume":"52","author":"Kloetgen","year":"2020","journal-title":"Nat Genet"},{"key":"2026111109162702000_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.molcel.2024.11.040","article-title":"3D chromatin hubs as regulatory units of identity and survival in human acute leukemia","volume":"85","author":"Gambi","year":"2025","journal-title":"Mol Cell"},{"key":"2026111109162702000_bib40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","article-title":"HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)","volume":"106","author":"Soulier","year":"2005","journal-title":"Blood"},{"key":"2026111109162702000_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"2026111109162702000_bib42","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat Genet"},{"key":"2026111109162702000_bib43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Homminga","year":"2011","journal-title":"Cancer Cell"},{"key":"2026111109162702000_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.1676542","article-title":"Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia","volume":"253","author":"Hatano","year":"1991","journal-title":"Science"},{"key":"2026111109162702000_bib45","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.leu.2402249","article-title":"A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia","volume":"15","author":"Bernard","year":"2001","journal-title":"Leukemia"},{"key":"2026111109162702000_bib46","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.3900","article-title":"Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia","volume":"49","author":"Seki","year":"2017","journal-title":"Nat Genet"},{"key":"2026111109162702000_bib47","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1038\/s41467-021-24044-5","article-title":"3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"2026111109162702000_bib48","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/leu.2011.119","article-title":"Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2","volume":"25","author":"Chen","year":"2011","journal-title":"Leukemia"},{"key":"2026111109162702000_bib49","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2012.02.013","article-title":"TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCR\u03b1 gene expression","volume":"21","author":"Dadi","year":"2012","journal-title":"Cancer Cell"},{"issue":"Suppl 51","key":"2026111109162702000_bib50","first-page":"Ol785","article-title":"Regulation of organ development by the NKX-homeodomain factors: an NKX code","volume":"51","author":"Stanfel","year":"2005","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"2026111109162702000_bib51","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nature06358","article-title":"Characterizing the cancer genome in lung adenocarcinoma","volume":"450","author":"Weir","year":"2007","journal-title":"Nature"},{"key":"2026111109162702000_bib52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/j.1460-2075.1990.tb08126.x","article-title":"The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein","volume":"9","author":"Chen","year":"1990","journal-title":"Embo j"},{"key":"2026111109162702000_bib53","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1073\/pnas.88.24.11416","article-title":"TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia","volume":"88","author":"Xia","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026111109162702000_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0092-8674(89)90404-2","article-title":"lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif","volume":"58","author":"Mellentin","year":"1989","journal-title":"Cell"},{"key":"2026111109162702000_bib55","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1073\/pnas.88.10.4367","article-title":"The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13","volume":"88","author":"Boehm","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026111109162702000_bib56","first-page":"1887","article-title":"TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11)","volume":"6","author":"Royer-Pokora","year":"1991","journal-title":"Oncogene"},{"key":"2026111109162702000_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrc3418","article-title":"LIM-domain-only proteins in cancer","volume":"13","author":"Matthews","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2026111109162702000_bib58","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2012-09-458570","article-title":"Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL","volume":"122","author":"McCormack","year":"2013","journal-title":"Blood"},{"key":"2026111109162702000_bib59","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1084\/jem.177.4.965","article-title":"Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha\/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes","volume":"177","author":"Breit","year":"1993","journal-title":"J Exp Med"},{"key":"2026111109162702000_bib60","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41588-020-0659-5","article-title":"Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X","volume":"52","author":"Liu","year":"2020","journal-title":"Nat Genet"},{"key":"2026111109162702000_bib61","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2006-04-019927","article-title":"The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia","volume":"108","author":"Van Vlierberghe","year":"2006","journal-title":"Blood"},{"key":"2026111109162702000_bib62","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.emboj.7600217","article-title":"Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7","volume":"23","author":"Yada","year":"2004","journal-title":"Embo j"},{"key":"2026111109162702000_bib63","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.stem.2016.08.004","article-title":"MED12 regulates HSC-specific enhancers independently of mediator kinase activity to control hematopoiesis","volume":"19","author":"Aranda-Orgilles","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2026111109162702000_bib64","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2009-04-214619","article-title":"Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis","volume":"114","author":"Stumpo","year":"2009","journal-title":"Blood"},{"key":"2026111109162702000_bib65","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1101\/gad.1239604","article-title":"Tel\/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival","volume":"18","author":"Hock","year":"2004","journal-title":"Genes Dev"},{"key":"2026111109162702000_bib66","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1158\/2159-8290.CD-23-1452","article-title":"Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2\/STAG2 rearrangements as extremely high risk","volume":"14","author":"Kimura","year":"2024","journal-title":"Cancer Discov"},{"key":"2026111109162702000_bib67","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ng.2731","article-title":"Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms","volume":"45","author":"Kon","year":"2013","journal-title":"Nat Genet"},{"key":"2026111109162702000_bib68","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"2026111109162702000_bib69","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.aaz3418","article-title":"DNA loop extrusion by human cohesin","volume":"366","author":"Davidson","year":"2019","journal-title":"Science"},{"key":"2026111109162702000_bib70","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.8079170","article-title":"Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages","volume":"265","author":"Scott","year":"1994","journal-title":"Science"},{"key":"2026111109162702000_bib71","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41375-019-0626-2","article-title":"DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes","volume":"34","author":"Kimura","year":"2020","journal-title":"Leukemia"},{"key":"2026111109162702000_bib72","first-page":"5329","article-title":"The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2)","volume":"63","author":"Nagel","year":"2003","journal-title":"Cancer Res"},{"key":"2026111109162702000_bib73","doi-asserted-by":"crossref","first-page":"e70154","DOI":"10.1002\/hem3.70154","article-title":"Oncogenomic profiling in infant\u2013toddler T-ALL identifies NKX2 family genes as drivers linked to favorable outcomes","volume":"9","author":"Delafoy","year":"2025","journal-title":"Hemasphere"},{"key":"2026111109162702000_bib74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41375-022-01743-6","article-title":"How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing","volume":"37","author":"M\u00fcller","year":"2023","journal-title":"Leukemia"},{"key":"2026111109162702000_bib75","doi-asserted-by":"crossref","first-page":"e2120787119","DOI":"10.1073\/pnas.2120787119","article-title":"Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases","volume":"119","author":"Dai","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026111109162702000_bib76","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s43018-024-00863-5","article-title":"A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia","volume":"6","author":"Xu","year":"2025","journal-title":"Nat Cancer"},{"key":"2026111109162702000_bib77","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.2024027270","article-title":"Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome","volume":"145","author":"Chen","year":"2025","journal-title":"Blood"},{"key":"2026111109162702000_bib78","doi-asserted-by":"crossref","first-page":"eadr2012","DOI":"10.1126\/scitranslmed.adr2012","article-title":"An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup","volume":"17","author":"Gower","year":"2025","journal-title":"Sci Translational Med"},{"key":"2026111109162702000_bib79","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood.2024027020","article-title":"NOTCH1 dimeric signaling is essential for T-cell leukemogenesis and leukemia maintenance","volume":"145","author":"Tamiro","year":"2025","journal-title":"Blood"},{"key":"2026111109162702000_bib80","doi-asserted-by":"crossref","first-page":"9397","DOI":"10.1038\/s41467-025-65049-8","article-title":"A non-canonical lymphoblast in refractory childhood T-cell leukaemia","volume":"16","author":"Lim","year":"2025","journal-title":"Nat Commun"},{"key":"2026111109162702000_bib81","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/2643-3230.BCD-20-0059","article-title":"Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia","volume":"1","author":"Roels","year":"2020","journal-title":"Blood Cancer Discov"},{"key":"2026111109162702000_bib82","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2009-04-214668","article-title":"DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia","volume":"115","author":"Milani","year":"2010","journal-title":"Blood"},{"key":"2026111109162702000_bib83","doi-asserted-by":"crossref","first-page":"eabc4834","DOI":"10.1126\/scitranslmed.abc4834","article-title":"Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup","volume":"13","author":"Touzart","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026111109162702000_bib84","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s43018-022-00370-5","article-title":"Acute lymphoblastic leukemia displays a distinct highly methylated genome","volume":"3","author":"Hetzel","year":"2022","journal-title":"Nat Cancer"},{"key":"2026111109162702000_bib85","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1200\/JCO.22.02734","article-title":"The clinicogenomic landscape of induction failure in childhood and young adult T-cell acute lymphoblastic leukemia","volume":"41","author":"O\u2019Connor","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026111109162702000_bib86","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","article-title":"Toward a NOTCH1\/FBXW7\/RAS\/PTEN\u2013based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a group for research in adult acute lymphoblastic leukemia study","volume":"31","author":"Trinquand","year":"2013","journal-title":"J Clin Oncol"},{"key":"2026111109162702000_bib87","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2022017755","article-title":"Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL","volume":"141","author":"Simonin","year":"2023","journal-title":"Blood"},{"key":"2026111109162702000_bib88","doi-asserted-by":"crossref","first-page":"e65373","DOI":"10.1371\/journal.pone.0065373","article-title":"Promoter DNA methylation pattern identifies prognostic subgroups in childhood T-cell acute lymphoblastic leukemia","volume":"8","author":"Borss\u00e9n","year":"2013","journal-title":"PLoS One"},{"key":"2026111109162702000_bib89","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood.2024026027","article-title":"CpG island methylator phenotype classification improves risk assessment in pediatric T-cell acute lymphoblastic leukemia","volume":"145","author":"Sch\u00e4fer Hackenhaar","year":"2025","journal-title":"Blood"},{"key":"2026111109162702000_bib90","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s43018-020-00167-4","article-title":"Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia","volume":"2","author":"Gocho","year":"2021","journal-title":"Nat Cancer"},{"key":"2026111109162702000_bib91","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.2021015106","article-title":"Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia","volume":"140","author":"Laukkanen","year":"2022","journal-title":"Blood"},{"key":"2026111109162702000_bib92","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1038\/bcj.2017.87","article-title":"In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL","volume":"7","author":"Laukkanen","year":"2017","journal-title":"Blood Cancer J"},{"key":"2026111109162702000_bib93","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41408-024-01180-x","article-title":"The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia","volume":"14","author":"Toscan","year":"2024","journal-title":"Blood Cancer J"},{"key":"2026111109162702000_bib94","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1182\/blood.2025028985","article-title":"Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia","volume":"146","author":"Montefiori","year":"2025","journal-title":"Blood"},{"key":"2026111109162702000_bib95","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood.2025028566","article-title":"STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALL","volume":"145","author":"Xu","year":"2025","journal-title":"Blood"},{"key":"2026111109162702000_bib96","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/leu.2017.136","article-title":"JAK\/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","volume":"31","author":"Delgado-Martin","year":"2017","journal-title":"Leukemia"},{"key":"2026111109162702000_bib97","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","article-title":"Efficacy of JAK\/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"key":"2026111109162702000_bib98","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1158\/1078-0432.CCR-22-2562","article-title":"Integration of genomic sequencing drives therapeutic targeting of PDGFRA in T-cell acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"29","author":"Paolino","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026111109162702000_bib99","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1182\/blood-2006-04-014514","article-title":"NUP214-ABL1 in adult T-ALL: the GMALL study group experience","volume":"108","author":"Burmeister","year":"2006","journal-title":"Blood"},{"key":"2026111109162702000_bib100","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/leu.2008.80","article-title":"Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies","volume":"22","author":"Quint\u00e1s-Cardama","year":"2008","journal-title":"Leukemia"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-25-0206\/3765934\/bcd-25-0206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/3\/353\/3783145\/bcd-25-0206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/3\/353\/3783145\/bcd-25-0206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:16:43Z","timestamp":1794406603000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/7\/3\/353\/784445\/Genomic-Insights-into-the-Biology-of-T-lineage"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":100,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,9]]},"published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-25-0206","relation":{},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}